Pharma execs talk digital therapeutic pricing. Germany reimburses first two prescribable apps.

Issue 073

Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week I wrote about what investors look for in digital therapeutics startups, why Proteus failed (according to its two founders) and more. Here's what's happening this week:

Juicy rumor: UnitedHealth is reportedly eyeing an acquisition of Amwell (nee American Well), according to financial services

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Pharma execs talk digital therapeutic pricing. Germany reimburses first two prescribable apps.

Welcome to E&O.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.